Related Experiment Video
Updated: Feb 20, 2026

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.3K
Clinicopathological correlations in behavioural variant frontotemporal dementia
David C Perry1, Jesse A Brown1, Katherine L Possin1
1Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Brain : a Journal of Neurology
|October 21, 2017
Summary
Predicting the exact cause of behavioural variant frontotemporal dementia (bvFTD) is challenging. Combining clinical, imaging, and genetic data improves pathological diagnosis accuracy for FTD and other neurodegenerative diseases.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Accurate neuropathological diagnosis in behavioural variant frontotemporal dementia (bvFTD) is crucial for developing effective disease-modifying therapies.
- bvFTD diagnosis presents a significant clinical challenge, necessitating improved methods for pathological prediction.
Purpose of the Study:
- To enhance pathological prediction in bvFTD by examining clinicopathological correlations in a large patient cohort.
- To identify common and distinct pathological features across various bvFTD subtypes and related conditions.
Main Methods:
- Analysis of autopsy data from 117 patients with a clinical diagnosis of bvFTD.
- Categorization of frontotemporal lobar degeneration (FTLD) into FTLD-tau, FTLD-TDP, FTLD-FUS, and FTLD-UPS subtypes.
- Voxel-based morphometry to identify patterns of brain atrophy.
- Discriminant function analysis incorporating clinical, neuroimaging, and neuropsychological data.
Main Results:
- Frontotemporal lobar degeneration (FTLD) was the most common pathology (98 patients), followed by Alzheimer's disease (15) and amyotrophic lateral sclerosis (4).
- Specific FTLD subtypes included FTLD-tau (34), FTLD-TDP (55), and FTLD-FUS (8).
- Shared atrophy in the anterior cingulate, frontoinsula, striatum, and amygdala was observed across most pathological subgroups.
- Data-driven classification achieved up to 60.2% accuracy by combining predictive factors and discriminant function analysis.
Conclusions:
- While core bvFTD features are common across FTLD-tau and FTLD-TDP, distinct symptom profiles suggest varied anatomical vulnerabilities.
- Degeneration in specific brain regions is closely linked to the behavioural syndrome in bvFTD, regardless of the underlying aetiology.
- A multi-modal approach combining clinical, imaging, genetic, and neuropsychological data significantly improves the accuracy of predicting pathological diagnoses in bvFTD.
Related Concept Videos
Biological Causes of Schizophrenia
740
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
740
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K

